Epstein-barr Virus-associated Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-03-09
Clinical Trial Update: Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors [Phase 1]
Phase 1 clinical study of a therapeutic immunological agent for Epstein-Barr virus-associated malignancies; currently active but not recruit…